Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 17 (2) , 127-135
- https://doi.org/10.1016/0165-5728(88)90020-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Demyelination and neurological signs in experimental allergic encephalomyelitisJournal of Neuroimmunology, 1987
- Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis ratsJournal of Neuroimmunology, 1986
- Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.The Journal of Experimental Medicine, 1984
- Chronic experimental allergic encephalomyelitis produced by bovine proteolipid apoprotein: Immunological studies in rabbitsAnnals of Neurology, 1983
- Cellular transfer of experimental allergic encephalomyelitis in Lewis rats: Effects of different sensitization regimens on in vitro reactivity of donor spleen cells to concanavalin ACellular Immunology, 1981
- LIPOSOMES CONTAINING MYELIN BASIC PROTEIN (BP) SUPPRESS BUT DO NOT INDUCE ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATSImmunology & Cell Biology, 1981
- Large Scale Preparation of Myelin Basic Protein from Central Nervous Tissue of Several Mammalian SpeciesPreparative Biochemistry, 1972
- STUDIES ON ANTIGENIC COMPETITIONThe Journal of Experimental Medicine, 1969
- Antigenic Competition: Cellular or HumoralScience, 1967